Kenan Turnacioglu
Venture Capital
General Partner and Investment Committee member at Catalio Capital Management, a healthcare/biotech-focused venture firm. Chairman of Paige (AI pathology, spun out of Memorial Sloan Kettering) and board member of Massive Bio and Immunai. Previously co-founded PointState Capital (2011-2018) managing healthcare investments, and worked at Duquesne Capital Management (2001-2010).
New York · 1+ investments
Seed
Early Stage
Growth
Late Stage
Artificial Intelligence
Biotech
Diagnostics
Healthcare
Life Sciences
Medical Devices
- Headquarters
- New York
- Website
- cataliocapital.com
- AUM
- $2.0B
- Total Investment
- 1
- Last Investment
- Dec 2022
- Geographic Focus
- United Kingdom, United States
Investment Thesis
As General Partner and Investment Committee member at Catalio Capital Management, Turnacioglu backs healthcare innovation across the full lifecycle (private, public, credit markets) and all stages, building category-defining businesses via rigorous scientific due diligence with expert-advisor networks.
Kenan Turnacioglu is a Venture Capital firm based in New York. It has made 1 investment in Artificial Intelligence and Biotech.
Investment History
Sign up to view investment history
Create a free account — 10 credits a month to unlock deal history, amounts, and round details.